Multifaceted scientist and research director with over two decades of expertise and leadership experience in computational drug discovery and development in the pharmaceutical industry. Visionary and strategic mindset, offering an in-depth understanding and a systemic perspective of the integration of model-driven strategies to empower transformative decision-making across the drug discovery and development value chain (from early drug design through preclinical, translational, and clinical development).Skilled in leading, coaching, and nurturing multidisciplinary teams using emotional intelligence, fostering synergies and a collaborative culture for continuous innovation and growth.Contributed actively to the invention and development of marketed antiparkinsonian drug ONgentys®, antiepileptic Zebinix®/Aption®, IND Zamicastat (pulmonary arterial hypertension) and many other drug candidate programmes in the therapeutic areas of neurological and cardiovascular disorders. Co-authored over 35 scientific publications and 8 drug patent families covering several drug candidates and treatments; Proven track record of successfully developing integrated approaches and driving advancements in physics-based and AI/ML-based computational molecular design and optimization, data science, pharmacometrics biosimulation and digital transformation initiatives within R&D.Areas of expertise and experience:• Computer Aided Drug Design (CADD)• Computational chemistry and cheminformatics• AI/Machine Learning• Pharmacometrics modelling and Simulation• Digital transformation and Discovery Informatics Platforms